China, America and pay inject drama into AstraZeneca’s AGM
The boss’s bonus is an annual debating point at Britain’s biggest company.But that’s not the only issue this yearAstraZeneca is used to facing protests over pay at its annual general meetings, given the position of its chief executive, Pascal Soriot, as the best-paid FTSE 100 chief executive for most of the past five years.But pay is not the only issue overshadowing this year’s virtual gathering on Friday.Britain’s biggest listed company, valued at about £170bn, faces investigations in China over import and data breaches, while it ran into controversy when it ditched the planned £450m expansion of its vaccine site in Speke, near Liverpool, in late January, after failing to hammer out a state support package with the UK government.On top of these problems comes the prospect – so far unrealised – of Donald Trump slapping tariffs on the pharmaceutical industry as part of his continuing attack on global trade practices.
The company’s chair, Michel Demaré, will at least be able to reflect on a year that was financially successful.Strong sales of AstraZeneca’s cancer, lung and immunology treatments lifted 2024 profits 38% higher to $8.7bn, with revenues up by 21% to $54.1bn.The group is confidently predicting a jump in revenues to $80bn by 2030, as it is betting on the launch of 20 new medicines.
This impressive financial performance has been clouded by trouble in China, where AstraZeneca is one of the biggest multinational pharma businesses.Its shares have risen by just 9% in the past 12 months, while they are up by nearly 60% in the last five years.China is the company’s second biggest market after the US, and news broke in September that several former and current executives were being investigated over allegations of importing unlicensed cancer medications and patient data breaches.The head of AstraZeneca’s China business, Leon Wang, who led its rapid growth there in recent years, stood down in late October after being detained by the authorities.AstraZeneca said in early February it could be fined up to $4.
5m if it was found liable over suspected unpaid importation taxes of $900,000 relating to its cancer drugs Imfinzi and Imjudo.There is also a separate investigation into alleged medical insurance fraud by AstraZeneca employees in China, which began in 2021.Then, just over a week ago, the group revealed a $2.5bn investment to establish its sixth international strategic research and development hub, set to be located in Beijing, in a sign that it may avoid severe penalties in China.The Beijing site will be the second in the country, after its existing facility in Shanghai.
Investors will be breathing a sigh of relief if AstraZeneca can put its China troubles behind it, but tariffs are another concern.So far, pharmaceuticals have been spared by the bruising new US tariffs, but if they were included, the cost of medications could rise around the world.The industry relies on long and complicated supply chains that involve many countries.Both AstraZeneca and the UK’s other big drug maker, GSK, have some manufacturing in the US, their No 1 market, which means they can mitigate against any tariffs to an extent.Last autumn, AstraZeneca said it was investing a further $3.
5bn in US research and manufacturing.But its decision not to expand in Speke is a blow to the country, with Tom Keith-Roach, AstraZeneca’s UK president, recently describing Britain as “an outlier now as one of the most difficult places in the world” in which to bring new medications to patients.Added to all this, AstraZeneca is unlikely to escape renewed scrutiny of its remuneration policy.Soriot, who joined from Roche in 2012, has successfully rebuilt AstraZeneca’s drug portfolio since fending off a hostile takeover bid from US rival Pfizer in 2014.The company has rewarded him with ever-higher pay packets, prompting almost 40% of shareholders to vote against, or abstain from voting on, his maximum £18.
7m package last year,He was paid £14,7m in the end, but this year his package could go up to £25m, depending on targets being met and a rise in the share price,AstraZeneca argues this is needed to attract and retain talent, and that the new pay policy simply brings Soriot’s pay more into line with that of global pharma executives,The investor advisory group Institutional Shareholder Services says: “Questions may be posed as to whether the remuneration committee’s response to the significant dissent to remuneration proposals at the last AGM has sufficiently assuaged shareholder concerns raised regarding variable pay.
”However, it adds that “there is evidence of performance targets being made more robust” and there are “no fresh concerns” at this time.Andrew Speke of the High Pay Centre thinktank says: “While in general, most people would consider the pay of some of the lowest-paid FTSE 100 chief executives to be far too high, Pascal Soriot’s pay levels have been viewed somewhat more sympathetically due to AstraZeneca’s role in developing vaccines during the Covid pandemic.”However, he argues that this year’s potential pay rise “deserves much greater scrutiny.Such extreme pay levels will only raise greater concerns among critics of big pharma that the companies producing life-saving drugs are primarily focused on enriching their executives and shareholders.”
Stephen Colbert on Trump tariffs: ‘America is finally free from the tyranny of being able to buy stuff from other countries’
Late-night hosts delve into Donald Trump’s so-called “liberation day” of tariffs and the defeat of an Elon Musk-backed candidate in the Wisconsin supreme court race.Donald Trump finally announced his tariff plan on Wednesday, a day he referred to as “liberation day”. Or, in other words, “thanks to Donald Trump, America is finally free from the tyranny of being able to buy stuff from other countries,” Stephen Colbert joked on Wednesday evening. “Who’s ready to learn how to make their own iPad from scratch?”“For a guy who’s been touting tariffs for months, seems like this all came together at the last minute,” the Late Show host continued. Trump was reportedly weighing tariff options as late as Tuesday night
‘No agenda’ in Guardian investigation of Noel Clarke, high court hears
There was “no agenda” in the Guardian’s investigation of sexual misconduct allegations against Noel Clarke, the high court has heard.In her second day in the witness box, Lucy Osborne, an investigative correspondent at the Guardian, defended the publication’s reporting in the face of questioning from the former Doctor Who star’s barrister, Philip Williams.Osborne, co-author of the investigation that led to the actor’s libel claim, denied Williams’s assertions that there were “major inconsistencies” in the accounts of alleged victims or that there was a conspiracy to bring down Clarke.She said that if there had been any concerns, she would have flagged them to the Guardian’s head of investigations, Paul Lewis.“There was no agenda,” Osborne told the court on Wednesday
Sara Pascoe: ‘I still identify as an infertile, childless woman’
The standup used to joke about not having kids, but then she had IVF and found herself an ‘eroded’ mother of two. Now she’s back with a show about motherhood in her 40s – but don’t expect any cute parenting storiesMy favourite Sara Pascoe joke is her imaginary riposte to people asking if she’s going to have kids. They mean well, these prying parents – they just don’t want her to miss out on a life-enhancing experience. The thing is, the comedian has had some life-enhancing experiences of her own. “But I have never, ever said to anybody: ‘Oh, have you been on QI? Ahhh, you should go on QI!’” she insists, settling into her archly patronising pep talk
‘My father’s death saved my life’: director Steve McQueen on grief, gratitude and getting cancer
After his dad died at 67, the 12 Years a Slave film-maker knew it was only a matter of time before he would get prostate cancer, too. The disease kills 12,000 men a year in the UK – a disproportionate number of them black. Now, in a bid to save lives, he is speaking out about his own diagnosis, alongside the doctors who successfully treated himSteve McQueen felt relieved when he was diagnosed with prostate cancer. He had no symptoms, was perfectly fit, at the peak of his game. Yet the Oscar-winning film-maker and artist believed it was inevitable
From A Minecraft Movie to Black Mirror: a complete guide to this week’s entertainment
A Minecraft MovieOut now You know how it is – you’re hanging out minding your own business when you’re pulled through a random portal into a three-dimensional world made up of voxels. That’s the fate that befalls Jason Momoa, Sebastian Hansen, Emma Myers and Danielle Brooks, where they meet Jack Black in this adaptation of the popular game.SebastianOut now Twentysomething Max works at a literary magazine in London while side-hustling as sex worker Sebastian to get inspiration for his debut novel, but soon finds his double life leading to a new understanding of his own identity, in this acclaimed first film from Mikko Mäkelä.Death of a UnicornOut now Accidentally hitting an animal is any driver’s nightmare. But it’s worse when said animal is an honest-to-god unicorn
The Guide #185: How The Phantom Menace’s trade wars can help you understand our political moment
There are many scary things to come out of Trump’s tariffs. The world economy being thrown into chaos; spiralling prices; furious economic experts showing charts with big down arrows, using phrases like “gilt markets” and “share index undergrowth”, which I definitely understand. But the most terrifying thing – the thing that has made me truly believe that we are living in the End Times – is a panic-inducing realisation: The Phantom Menace just might have been right all along.For those who haven’t seen the first Star Wars prequel, GOD I envy you. The dialogue is wooden and the structure inexplicable (sure, let’s just have a pod-race instead of an Act II) – and that’s even before we get onto the Jar Jar Binks of it all (the answer to the question “what if we shaved Paddington and spliced his DNA with the most unlikeable newt in the world?”)
China, America and pay inject drama into AstraZeneca’s AGM
Sobering stuff: UK alcohol industry reels from impact of Trump tariffs
Companies House collects just £1,250 in fines in corruption crackdown
China needs friends in Trump’s trade war. But Xi may have to go it alone
The fallout from Trump’s tariffs: is there a masterplan, are we heading for recession and what does it mean for UK?
What are anti-dumping laws and why does Australia need them?